These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36413797)

  • 41. [Comparison of the combination and quinolone therapy in community acquired pneumonia].
    Kılıç Soylar Ö; Kılınç O; Ellidokuz H
    Tuberk Toraks; 2015 Sep; 63(3):165-9. PubMed ID: 26523897
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia.
    Mortensen EM; Restrepo MI; Anzueto A; Pugh J
    Crit Care; 2005 Dec; 10(1):R8. PubMed ID: 16420641
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
    Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Narrow-spectrum ß-lactam monotherapy in hospital treatment of community-acquired pneumonia: a register-based cohort study.
    Rhedin S; Galanis I; Granath F; Ternhag A; Hedlund J; Spindler C; Naucler P
    Clin Microbiol Infect; 2017 Apr; 23(4):247-252. PubMed ID: 28017793
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative Effectiveness of First-Line and Alternative Antibiotic Regimens in Hospitalized Patients With Nonsevere Community-Acquired Pneumonia: A Multicenter Retrospective Cohort Study.
    Bai AD; Srivastava S; Wong BKC; Digby GC; Razak F; Verma AA
    Chest; 2024 Jan; 165(1):68-78. PubMed ID: 37574164
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of intravenous {beta}-lactam/macrolide versus {beta}-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia.
    Tessmer A; Welte T; Martus P; Schnoor M; Marre R; Suttorp N
    J Antimicrob Chemother; 2009 May; 63(5):1025-33. PubMed ID: 19293196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia.
    Teh B; Grayson ML; Johnson PD; Charles PG
    Clin Microbiol Infect; 2012 Apr; 18(4):E71-3. PubMed ID: 22284533
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Macrolide combination therapy for patients hospitalised with community-acquired pneumonia? An individualised approach supported by machine learning.
    König R; Cao X; Oswald M; Forstner C; Rohde G; Rupp J; Witzenrath M; Welte T; Kolditz M; Pletz M;
    Eur Respir J; 2019 Dec; 54(6):. PubMed ID: 31537702
    [TBL] [Abstract][Full Text] [Related]  

  • 49. β-Lactam/macrolide dual therapy versus β-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis.
    Nie W; Li B; Xiu Q
    J Antimicrob Chemother; 2014 Jun; 69(6):1441-6. PubMed ID: 24535276
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prescribing trends and revisit rates following a pharmacist-driven protocol change for community-acquired pneumonia in an emergency department.
    Zimmerman DE; Covvey JR; Nemecek BD; Guarascio AJ; Wilson L; Freedy HR; Yassin MH
    Int J Pharm Pract; 2019 Jun; 27(3):279-285. PubMed ID: 30536468
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Hypothesis-Generating Study of the Combination of Aspirin plus Macrolides in Patients with Severe Community-Acquired Pneumonia.
    Falcone M; Russo A; Shindo Y; Farcomeni A; Pieralli F; Cangemi R; Liu J; Xia J; Okumura J; Sano M; Jones C; Vannucchi V; Mancone M; Micek S; Xu F; Violi F; Kollef M
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Comparison of ampicillin-sulbactam/macrolide dual therapy versus fluoroquinolone monotherapy in hospitalized patients with community-acquired pneumonia].
    Karaboğa B; Çilli A
    Tuberk Toraks; 2015 Jun; 63(2):94-101. PubMed ID: 26167966
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibiotic Therapy for Adults Hospitalized With Community-Acquired Pneumonia: A Systematic Review.
    Lee JS; Giesler DL; Gellad WF; Fine MJ
    JAMA; 2016 Feb; 315(6):593-602. PubMed ID: 26864413
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnosis and management of community-acquired pneumonia in adults.
    Watkins RR; Lemonovich TL
    Am Fam Physician; 2011 Jun; 83(11):1299-306. PubMed ID: 21661712
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Atypical coverage in community-acquired pneumonia after outpatient beta-lactam monotherapy.
    van Werkhoven CH; van de Garde EMW; Oosterheert JJ; Postma DF; Bonten MJM
    Respir Med; 2017 Aug; 129():145-151. PubMed ID: 28732822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The dilemma of monotherapy or combination therapy in community-acquired pneumonia.
    Vardakas KZ; Trigkidis KK; Apiranthiti KN; Falagas ME
    Eur J Clin Invest; 2017 Dec; 47(12):. PubMed ID: 29027205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibiotic treatment of moderate-severe community-acquired pneumonia: design and rationale of a multicentre cluster-randomised cross-over trial.
    van Werkhoven CH; Postma DF; Oosterheert JJ; Bonten MJ
    Neth J Med; 2014 Apr; 72(3):170-8. PubMed ID: 24846935
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fluoroquinolones or macrolides in combination with β-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis.
    Vardakas KZ; Trigkidis KK; Falagas ME
    Clin Microbiol Infect; 2017 Apr; 23(4):234-241. PubMed ID: 27965070
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Macrolides and mortality in critically ill patients with community-acquired pneumonia: a systematic review and meta-analysis.
    Sligl WI; Asadi L; Eurich DT; Tjosvold L; Marrie TJ; Majumdar SR
    Crit Care Med; 2014 Feb; 42(2):420-32. PubMed ID: 24158175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.